Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of COL-118 Facial Gel vs Brimonidine Ophthalmic Solution in Rosacea
NCT00697541Phase 2Completed
- Sponsor
- Galderma
- Start
- May 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brimonidine transdermal lotion in Erythematotelangiectatic Rosacea (ETR), sponsored by Galderma. Started May 2008; status: completed.
02
Drugs
brimonidine transdermal lotion
03
Conditions
Erythematotelangiectatic Rosacea (ETR)
Beyond the preview
Go deeper on NCT00697541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697541.